Relationship between hepatic iron deposits and response to interferon in chronic hepatitis C

American Journal of Gastroenterology

Volumn 91, Issue 7, 1996, Pages 1367-1373

  Ikura, Yoshihiro ^a   Morimoto, Hideki ^b   Johmura, Hisato ^b   Fukui, Mitsuru ^b   Sakurai, Masami ^b  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; FERRIC FERROCYANIDE; FERRITIN; IRON; RECOMBINANT ALPHA INTERFERON; VIRUS RNA;

ADULT; AGED; ARTICLE; CLINICAL PROTOCOL; DISEASE SEVERITY; FEMALE; FERRITIN BLOOD LEVEL; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IRON BLOOD LEVEL; IRON STORAGE; LIVER BIOPSY; LIVER CELL; LIVER FIBROSIS; LIVER SINUSOID; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; ANTIVIRAL AGENTS; BIOPSY, NEEDLE; CHRONIC DISEASE; FEMALE; HEPATITIS C; HUMANS; INTERFERON TYPE I, RECOMBINANT; INTERFERON-ALPHA; IRON; LIVER; MALE; MIDDLE AGED; PROGNOSIS; REMISSION INDUCTION; TIME FACTORS;

EID: 0030037708     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Choo Q-L, Kuo G, Weiner AJ, et al. Isolation of a cDNA clone derived from a blood-borne non-A, non-B, viral hepatitis genome. Science 1989;244:359-62.
2. Kuo G, Choo Q-L, Alter HJ, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989;244:362-4.
3. Nishioka K, Watanabe J, Furuta S, et al. Antibody to the hepatitis C virus in acute hepatitis and chronic liver diseases in Japan. Liver 1991;11:65-70.
4. Tanaka K, Hirohata T, Koga S, et al. Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population. Cancer Res 1991;51:2842-7.
5. Watanabe J, Matsumoto C, Fujimura K, et al. Predictive value of screening tests for persistent hepatitis C virus infection evidenced by viraemia: Japanese experience. Vox Sang 1993;65:199-203.
6. Brown GE, Lebleu B, Kawakita M, et al. Increased endonuclease activity in an extract from mouse Ehrlich ascites tumor cells which had been treated with a partially purified interferon preparation: Dependence on double-stranded RNA. Biochem Biophys Res Commun 1976;69:114-22.
7. Nilsen TW, Weissman SG, Baglioni C. Role of 2′,5′-oligo(adenylic acid) polymerase in the degradation of ribonucleic acid linked to double-stranded ribonucleic acid by extracts of interferon-treated cells. Biochemistry 1980;19:5574-9.
8. Kanai K, Kako M, Okamoto H. HCV genotypes in chronic hepatitis C and response to interferon. Lancet 1992;339:1543.
9. Yoshioka K, Kakumu S, Wakita T, et al. Detection of hepatitis C virus by polymerase chain reaction and response to interferon-α therapy: Relationship to genotypes of hepatitis C virus. Hepatology 1992;16: 293-9.
10. Kobayashi Y, Watanabe S, Konishi M, et al. Quantitation and typing of serum hepatitis C virus RNA in patients with chronic hepatitis C treated with interferon-β. Hepatology 1993;18:1319-25.
11. Camps J, Crisóstomo S, Garća-Granero M, et al. Prediction of the response of chronic hepatitis C to interferon alfa: A statistical analysis of pretreatment variables. Gut 1993;34:1714-7.
12. Serfaty L, Giral P, Loria A, et al. Factors predictive of the response to interferon in patients with chronic hepatitis C. J Hepatol 1994;21:12-7.
13. Uchida T, Taira M, Shikata T, et al. Histological difference between complete responders and non-responders to interferon therapy of the livers of patients with chronic hepatitis C. Acta Pathol Jpn 1993;43: 230-6.
14. Van Thiel DH, Friedlander L, Fagiuoli S, et al. Response to interferon-α therapy is influenced by the iron content of the liver. J Hepatol 1994;20:410-5.
15. Di Bisceglie AM, Axiotis CA, Hoofnagle JH, et al. Measurements of iron status in patients with chronic hepatitis. Gastroenterology 1992; 102:2108-13.
16. Powell LW, Isselbacher KJ. Hemochromatosis. In: Wilson JD, Braunwald E, Petersdorf RG, et al., eds. Harrison's principles of internal medicine, 12th ed. New York: McGraw-Hill, 1991:1825-9.
17. Desmet VJ, Gerber M, Hoofnagle JH, et al. Classification of chronic hepatitis: Diagnosis, grading and staging. Hepatology 1994;19:1513-20.
18. Scheuer PJ. Liver biopsy interpretation, 4th ed. London: Baillière Tindall, 1988:12-15.
19. Deugnier YM, Loréal O, Turlin B, et al. Liver pathology in genetic hemochromatosis: A review of 135 homozygous cases and their bioclinical correlations. Gastroenterology 1992;102:2050-9.
20. Rowe JW, Wands JR, Mezey E, et al. Familial hemochromatosis: Characteristics of the precirrhotic stage in a large kindred. Medicine 1977;56:197-211.
21. Weintraub LR, Goral A, Grasso J, et al. Pathogenesis of hepatic fibrosis in experimental iron overload. Br J Haematol 1985;59:321-31.
22. Roberts FD, Charalambous P, Fletcher L, et al. Effect of chronic iron overload on procollagen gene expression. Hepatology 1993;18:590-5.
23. Aust SD, Morehouse LA, Thomas CE. Role of metals in oxygen radical reactions. J Free Radicals Biol Med 1985;1:3-25.
24. Jurkiewicz BA, Buettner GR. Ultraviolet light-induced free radical formation in skin: An electron paramagnetic resonance study. Photochem Photobiol 1994;59:1-4.
25. Kato J, Kohgo Y, Sugawara N, et al. Abnormal hepatic iron accumulation in LEC rats. Jpn J Cancer Res 1993;84:219-22.
26. Olynyk J, Reddy R, Di Bisceglie AM, et al. Hepatic iron concentration as a predictor of response to alpha interferon therapy in chronic hepatitis C. Hepatology 1993;18:90A.
27. Weiland O, Schvarcz R, Wejstål R, et al. Therapy of chronic post-transfusion non-A, non-B hepatitis with interferon alpha-2b: Swedish experience. J Hepatol 1990;11:S57-S62.